NYSE : GSK
$0.63 (1.23%)
GSK financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 2 | 3.03B | 3.25B | 3.15B | 2.48B | 2.66B | 2.58B |
| 2027-09-30 | 2 | 3.01B | 3.22B | 3.12B | 2.46B | 2.64B | 2.56B |
| 2027-06-30 | 2 | 2.75B | 2.94B | 2.85B | 2.25B | 2.41B | 2.34B |
| 2027-03-31 | 2 | 2.59B | 2.78B | 2.69B | 2.12B | 2.27B | 2.2B |
| 2026-12-31 | 2 | 2.91B | 3.12B | 3.02B | 2.38B | 2.55B | 2.47B |
| 2026-09-30 | 5 | 2.84B | 3.13B | 3B | 2.33B | 2.56B | 2.45B |
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 2 | 1.21B | 1.32B | 1.27B | 2.73B | 2.93B | 2.84B |
| 2027-09-30 | 2 | 2.4B | 2.62B | 2.52B | 2.71B | 2.91B | 2.82B |
| 2027-06-30 | 2 | 1.96B | 2.15B | 2.06B | 2.48B | 2.66B | 2.57B |
| 2027-03-31 | 2 | 2.02B | 2.21B | 2.12B | 2.34B | 2.51B | 2.43B |
| 2026-12-31 | 2 | 1.12B | 1.23B | 1.18B | 2.62B | 2.81B | 2.72B |
| 2026-09-30 | 5 | 2.12B | 2.21B | 2.18B | 2.56B | 2.82B | 2.7B |
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-31 | 2 | 9.04B | 9.7B | 9.4B | 1 | 0.5939 | 0.65038 | 0.62449 |
| 2027-09-30 | 2 | 8.97B | 9.62B | 9.32B | 1 | 1.17635 | 1.28821 | 1.23693 |
| 2027-06-30 | 2 | 8.2B | 8.79B | 8.52B | 1 | 0.96246 | 1.05399 | 1.01203 |
| 2027-03-31 | 2 | 7.73B | 8.29B | 8.04B | 1 | 0.99111 | 1.08536 | 1.04215 |
| 2026-12-31 | 2 | 8.67B | 9.3B | 9.01B | 1 | 0.55098 | 0.60338 | 0.57936 |
| 2026-09-30 | 5 | 8.49B | 9.35B | 8.95B | 3 | 1.04189 | 1.08471 | 1.07044 |